About NeuroPace
NeuroPace is a company based in United States founded in 1997.. NeuroPace has raised $263.56 million across 8 funding rounds from investors including Kleiner Perkins, Orbimed and Revelation Partners. The company has 184 employees as of December 31, 2024. NeuroPace offers products and services including RNS System. NeuroPace operates in a competitive market with competitors including Cadence Neuroscience, Engage Therapeutics, Cyberonics, CerboMed and NightWatch, among others.
- Headquarter United States
- Employees 184 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neuropace, Inc.
-
Annual Revenue
$79.91 M22.14as on Dec 31, 2024
-
Net Profit
$-27.14 M17.64as on Dec 31, 2024
-
EBITDA
$-19.9 M22.16as on Dec 31, 2024
-
Total Equity Funding
$263.56 M (USD)
in 8 rounds
-
Latest Funding Round
$69.39 M (USD), Series E
Aug 19, 2020
-
Investors
Kleiner Perkins
& 11 more
-
Employee Count
184
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NeuroPace
NeuroPace is a publicly listed company on the NASDAQ with ticker symbol NPCE in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of NeuroPace
NeuroPace offers a comprehensive portfolio of products and services, including RNS System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers personalized therapy to reduce seizures in drug-resistant epilepsy patients.
Unlock access to complete
Unlock access to complete
Leadership Team
11 people
Software Development Team
8 people
Sales and Marketing
3 people
Human Resources and Administration
3 people
Product Management Team
2 people
Legal and Compliance
2 people
Senior Team
2 people
Data Analysis and Operations Team
2 people
Unlock access to complete
Funding Insights of NeuroPace
NeuroPace has successfully raised a total of $263.56M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $69.39 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series E — $69.4M
-
First Round
First Round
(09 Sep 2003)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Series E - NeuroPace | Valuation | Accelmed | |
| Sep, 2016 | Amount | Series E - NeuroPace | Valuation | Orbimed |
|
| Mar, 2014 | Amount | Grant - NeuroPace | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuroPace
NeuroPace has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Orbimed and Revelation Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuroPace
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuroPace
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neuropace Comparisons
Competitors of NeuroPace
NeuroPace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cadence Neuroscience, Engage Therapeutics, Cyberonics, CerboMed and NightWatch, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices for treating neurological disorders like epilepsy are developed.
|
|
| domain | founded_year | HQ Location |
Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures
|
|
| domain | founded_year | HQ Location |
Vagus nerve stimulation therapy is developed for epilepsy and depression.
|
|
| domain | founded_year | HQ Location |
Neuro-therapy solutions are developed for drug-resistant epilepsies and disorders.
|
|
| domain | founded_year | HQ Location |
Wearable armbands for detecting epileptic seizures during sleep are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neuropace
Frequently Asked Questions about NeuroPace
When was NeuroPace founded?
NeuroPace was founded in 1997 and raised its 1st funding round 6 years after it was founded.
Where is NeuroPace located?
NeuroPace is headquartered in United States.
Is NeuroPace a funded company?
NeuroPace is a funded company, having raised a total of $263.56M across 8 funding rounds to date. The company's 1st funding round was a Grant of $2.5M, raised on Sep 09, 2003.
How many employees does NeuroPace have?
As of Dec 31, 2024, the latest employee count at NeuroPace is 184.
What is the annual revenue of NeuroPace?
Annual revenue of NeuroPace is $79.91M as on Dec 31, 2024.
What does NeuroPace do?
Founded in 1997 in the United States, NeuroPace operates in the medical device sector, focusing on neurostimulation technologies. Implantable systems are designed to detect and respond to abnormal brain activity in adults with drug-resistant focal epilepsy, delivering targeted stimulation to reduce seizures. EEG data is collected and shared to support clinical monitoring and patient management. Resources, including support services, are provided to patients and healthcare professionals for ongoing care.
Who are the top competitors of NeuroPace?
NeuroPace's top competitors include Engage Therapeutics, Cyberonics and Cadence Neuroscience.
What products or services does NeuroPace offer?
NeuroPace offers RNS System.
Is NeuroPace publicly traded?
Yes, NeuroPace is publicly traded on NASDAQ under the ticker symbol NPCE.
Who are NeuroPace's investors?
NeuroPace has 12 investors. Key investors include Kleiner Perkins, Orbimed, Revelation Partners, Accelmed, and Soleus Capital.
What is NeuroPace's ticker symbol?
The ticker symbol of NeuroPace is NPCE on NASDAQ.